![[PukiWiki]](image/pukiwiki.png "[PukiWiki]")
#author("2024-12-07T09:13:21+09:00","","") There were positive correlations between monocytes and eosinophils (r=0.99), plasma cells and regulatory T cells (r=0.88), activated mast cells and dendritic cells (r=0.75) in NPC, while M1 macrophages were negatively correlated with memory B cells (r=-0.71) and activated memory CD4+T cells (r=-0.63). In addition, GO of differential genes in NPC was mainly enriched in the function related to ciliary movement, and KEGG was mainly enriched in the pathway related to cytochrome P450. CCDC39 was a key gene in NPC, which was highly expressed in NPC and beneficial to the prognosis of patients, but the low expression of memory B cells was not conducive to the prognosis of patients. Conclusion A large number of immune cells are distributed in the microenvironment of NPC, and the expression of different types of immune cells is different, but memory B cells have the most obvious effect on the prognosis of patients.Objective To investigate the role and mechanism of aldo-keto reductase 1 member B1 (AKR1B1) in regulating microglial cell polarization and thereby regulating the activity of retinal ganglion cells (RGCs). Methods Lipopolysaccharide (LPS) was used to induce BV-2 polarization in microglia cells. AKR1B1 siRNA and inhibitor ponalrestat/Statil were used to treat BV-2 cells, and the effect of AKR1B1 on cell polarization was identified through morphology and inflammatory cytokine expression detection, including tumor necrosis factor α(TNF-α), interleukin 1β(IL-1β), cyclooxygenase 2(COX2), and inducible nitric oxide synthase(iNOS). Primary RGCs were cultured with the indicated BV-2 conditional medium. The activity of RGCs was detected by brain-specific homeobox protein 3a (Brn-3a) immunofluorescence staining, and apoptosis was observed by TUNEL staining. The expression of phosphorylated IKK and p65 in the nucleus were detected by Western blotting. Results LPS induced M1-type polarization of BV-2 cells, while its conditioned medium induced decreased RGC activity and increased apoptosis. Inhibition of AKR1B1 blocked M1 type polarization of BV-2 cells and restored RGC activity. Inhibition of AKR1B1 can block LPS-induced IKK phosphorylation and NF-κBp65 nuclear localization. Conclusion AKR1B1 can induce microglial activation by activating NF-κB pathway, which in turn inhibit the activity and promote apoptosis of RGCs.Objective To explore the change of autophagy levels of the macrophages infected by Mycobacterium with different virulence. Methods RAW264.7 cells were infected with Mycobacterium tuberculosis standard strain (H37Rv), Bacille Calmette Guerin (BCG) and Mycobacterium smegmatis (Ms). The cell autophagy was detected by flow cytometry and the colocalization of phagosomes and lysosomes was detected by confocal laser scanning microscopy. Meanwhile, the autophagy-associated protein LC3, mTOR, p-mTOR, AKT and p-AKT were detected by Western blotting. Results At 24 hours after RAW264.7 cells were infected by Mycobacterium with different virulence, flow cytometry showed that the level of autophagy was significantly up-regulated by H37Rv, BCG and Ms infection, and the highest level was in the Ms infection group. The level of LC3-II was significantly up-regulated after H37Rv, BCG and Ms infection, and the tendency was consistent with the result of flow cytometry. The colocalization rates of phagosomes and lysosomes after H37Rv, BCG and Ms infection were (11.33±0.88)%, (18.33±0.88)% and (48.67±0.66)%. The expression of mTOR and AKT had no significant changes after H37Rv, BCG and Ms infection, but the phosphorylation level significantly increased, which meant that PI3K-AKT-mTOR was activated. Conclusion Mycobacterium infection can induce the autophagy in macrophages and promote the phosphorylation of mTOR and AKT.Acute vasitis, or inflammation of the vas deferens, is a rare condition that classically presents with unilateral groin pain radiating into the scrotum and a bulge or induration along the inguinal canal. As a result, it mimics and is often mistaken for more common pathologies such as inguinal hernia, epididymo-orchitis or testicular torsion. A misdiagnosis may lead to unnecessary surgery and morbidity. Here, we present a case of acute vasitis which was originally diagnosed as an incarcerated inguinal hernia. Finally, we review the imaging findings, which can often be subtle and misinterpreted or missed.Erdheim-Chester disease (ECD) is a rare systemic histiocytosis with urologic manifestations in a majority of affected patients. An important manifestation is a pronounced retroperitoneal fibrosis with reported dense inflammatory rind surrounding the kidneys. We report a case of a patient with large stone burden necessitating percutaneous nephrolithotomy and the implications related to his Erdheim-Chester-related retroperitoneal fibrotic changes. Foreknowledge of these implications may inform perioperative counseling and surgical planning to maximize opportunity for successful outcomes.Obesity is a known risk factor for recurrent nephrolithiasis and it can be challenging to provide safe surgical intervention in the super obese population. Despite high weight limits on surgical beds, these often do not take into account positioning the patient on the end of the bed for dorsal lithotomy, which can risk an unsteady bed. In addition, depending on patient habitus the leg stirrups may not accommodate. There is limited literature that discusses the technical approach for positioning super obese patients in dorsal lithotomy when the weight limit approaches or exceeds the capacity of equipment available. In this article, we present a modified positioning technique to improve bed stability, which also provides an alternative if the patient's legs are not supported by available leg stirrups. From our experience, this modified dorsal lithotomy positioning for ureteroscopy is feasible and safe in patients with super obesity. Surgical intervention on this population requires appropriate planning and teamwork to ensure safe positioning.Appropriate perioperative management of antithrombotic medications is critical; for every patient, the risk of bleeding must be balanced against individual risk of thrombosis. There has been a rapid influx of new antithrombotic therapies in the past 5 years, yet there is a lack of clear and concise guidelines on the management of anticoagulant and antiplatelet therapy during urologic surgery. Here we describe our approach to perioperative antithrombotic counseling, including the timing of stopping and restarting these medications. These practice guidelines have been developed in consultation with the Vascular Medicine service at our institution as well as after a review of current literature, and apply to common urologic procedures. https://www.selleckchem.com/products/shield-1.html Many cases are complex and require medical consultation or a multidisciplinary approach to management. We believe that by presenting our systematic method of antithrombotic management, including when to involve other discplines, we can increase knowledge and comfort amongst urologists in managing these medications in the perioperative period.
